Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.
about
Vaccines for Pseudomonas aeruginosa: a long and winding roadComplex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strainsSafety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection.Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate.Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 typeProtection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.Protection of immunosuppressed mice against infection with Pseudomonas aeruginosa by recombinant P. aeruginosa lipoprotein I and lipoprotein I-specific monoclonal antibodies.Bioengineering a bacterial pathogen to assemble its own particulate vaccine capable of inducing cellular immunity.Recent developments for Pseudomonas vaccines.Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.The Pathogenic Potential of a Microbe.A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.
P2860
Q26852817-DD8EB7CC-788E-4ACA-B2E4-6B9929D8C1FCQ33757770-4D761242-AD95-489B-8A9C-F6CAA0BA8CEBQ34000731-B9E3305C-ED5B-46B7-8E29-54B3014FD718Q34002814-3B19DDBC-840A-4B10-90FF-CAF92698EE0EQ34004684-C532F118-F1F1-44D9-8E4B-1F9C66E0DBAAQ34121084-FF60AF8A-BBFF-47DB-AFF6-3CFAF245E533Q35410420-C81DA4B4-E25B-4A21-974D-64E4620DB420Q36361980-760870D7-DC3B-4287-A0E3-F64A4A881EAAQ36961991-4774D531-627B-4C8F-A4EE-448BE0BC7571Q37620529-2D551B0E-57F0-431E-B75A-D3ACA1FFFFDEQ37937369-EEB80956-18C8-4A48-B344-1F843CB63858Q39859766-E096BA14-1DA6-4646-9AF1-4F1676E4E578Q40311700-D6C58A6C-C34C-4CFB-94B5-84F8C4BB1BE0Q43121719-4610F9F0-CDD5-4427-9D94-DCB264C7AC68
P2860
Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Protection against experimenta ...... expressed in Escherichia coli.
@en
type
label
Protection against experimenta ...... expressed in Escherichia coli.
@en
prefLabel
Protection against experimenta ...... expressed in Escherichia coli.
@en
P2093
P2860
P1476
Protection against experimenta ...... expressed in Escherichia coli.
@en
P2093
P2860
P304
P407
P577
1990-07-01T00:00:00Z